Snowden Capital Advisors’s Exelixis EXEL Stock Holding History
Bought
Maintained
Sold
Other funds holding EXEL
FCM
VPM
VCM
Snowden Capital Advisors's EXEL Position: Q1 2026 in Review
Snowden Capital Advisors increased its Exelixis (EXEL) stake by 5.4% in Q1 2026, buying an estimated $10.6K and bringing the position to 4,817 shares worth $207K. The position accounts for 0.01% of the portfolio, ranked #1208.
Snowden Capital Advisors first reported a position in EXEL in Q2 2022 and has held it in 5 quarters since. The position peaked at $420K in Q4 2022. 694 funds tracked by Wall St. Rank hold EXEL as of Q1 2026.
- Snowden Capital Advisors held 4,817 shares of Exelixis worth $207K as of Q1 2026.
- Snowden Capital Advisors bought 246 Exelixis shares in Q1 2026, an estimated $10.6K.
- Exelixis made up 0.01% of Snowden Capital Advisors's portfolio in Q1 2026, its #1208 holding.
- Snowden Capital Advisors first reported a position in Exelixis in Q2 2022 and has held it in 5 quarters since.
- Snowden Capital Advisors's Exelixis position peaked at $420K in Q4 2022.
- 694 funds tracked by Wall St. Rank held Exelixis as of Q1 2026.
Based on Snowden Capital Advisors's 13F filing for Q1 2026, filed 15 May 2026.